Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer (NSCLC)
This study has been terminated.
(See termination reason in detailed description.)
Sponsor:
Pfizer
Information provided by (Responsible Party):
Pfizer
ClinicalTrials.gov Identifier:
NCT00673049
First received: May 5, 2008
Last updated: May 21, 2012
Last verified: May 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | April 2012 |
| Primary Completion Date: | March 2011 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | April 22, 2011 |